Wegovy

Uses of Wegovy

Wegovy is a prescription medication designed to assist with weight loss in individuals who are overweight or have obesity. It contains the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Wegovy works by regulating appetite, leading to reduced food intake, increased feelings of fullness, and the promotion of healthy eating habits.

Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients with a body mass index (BMI) of 27 kg/m² or greater, who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia.

Wegovy is classified as a GLP-1 receptor agonist. It mimics the action of the hormone GLP-1, which helps regulate blood sugar levels and appetite.

Precautions of Wegovy

Before starting Wegovy, inform your healthcare provider of any underlying medical conditions or allergies. It is important to disclose any current medications or dietary supplements you are taking, as they may interact with Wegovy. This medication is not recommended for use during pregnancy or breastfeeding.

Please note that this description is a general overview, and it is essential to consult with a healthcare professional for more detailed and personalized information regarding the uses, drug classification, side effects, dosage, and precautions of Wegovy.

Dosage of Wegovy

The recommended dosage for Wegovy is an initial dose of 0.25 mg injected once weekly for four weeks, followed by an increased maintenance dose of 1.0 mg injected once weekly.

Side Effects:

Common side effects:

• Nausea,
• diarrhea,
• vomiting,
• abdominal pain,
• decreased appetite,
• constipation.

Serious side effect:

• pancreatitis,
• gallbladder problems.